Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3TNE

The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir

Summary for 3TNE
Entry DOI10.2210/pdb3tne/pdb
Related3FV3
Related PRD IDPRD_001001
DescriptorSecreted aspartic protease, RITONAVIR (3 entities in total)
Functional Keywordsaspartic acid endopeptidases, catalytic domain, ritonavir, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceCandida parapsilosis (Yeast)
Total number of polymer chains2
Total formula weight73172.21
Authors
Dostal, J.,Brynda, J.,Hruskova-Heidingsfeldova, O.,Pachl, P.,Pichova, I.,Rezacova, P. (deposition date: 2011-09-01, release date: 2012-03-07, Last modification date: 2024-11-27)
Primary citationDostal, J.,Brynda, J.,Hruskova-Heidingsfeldova, O.,Pachl, P.,Pichova, I.,Rezacova, P.
The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir.
J Enzyme Inhib Med Chem, 27:160-165, 2012
Cited by
PubMed Abstract: Secreted aspartic proteases (Saps) are extracellular proteolytic enzymes that enhance the virulence of Candida pathogens. These enzymes therefore represent possible targets for therapeutic drug design. Saps are inhibited by nanomolar concentrations of the classical inhibitor of aspartic proteases pepstatin A and also by the inhibitors of the HIV protease, but with the K(i) of micromolar values or higher. To contribute to the discussion regarding whether HIV protease inhibitors can act against opportunistic mycoses by the inhibition of Saps, we determined the structure of Sapp1p from Candida parapsilosis in complex with ritonavir (RTV), a clinically used inhibitor of the HIV protease. The crystal structure refined at resolution 2.4 Å proved binding of RTV into the active site of Sapp1p and provided the structural information necessary to evaluate the stability and specificity of the protein-inhibitor interaction.
PubMed: 22146051
DOI: 10.3109/14756366.2011.627508
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon